Search Count: 5,419
 |
The Crystal Structure Of Sars-Cov-2 Main Protease In Complex With An Iso-Quinoline-Derived Inhibitor Fd6-31
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION Release Date: 2025-12-17 Classification: VIRAL PROTEIN Ligands: A1EH0 |
 |
A Rare Open Conformation For Ubl2 Domain Of Papain-Like Protease C111S Of Sars-Cov2
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION Release Date: 2025-12-10 Classification: VIRAL PROTEIN Ligands: GOL, ZN, SO4 |
 |
Cryo-Em Structure Of Sars-Cov-2 Ba.5 Spike Protein In Complex With Nab 1C4 (Local Refinement)
Organism: Severe acute respiratory syndrome coronavirus 2, Mus musculus
Method: ELECTRON MICROSCOPY Release Date: 2025-12-10 Classification: VIRAL PROTEIN/IMMUNE SYSTEM |
 |
Cryo-Em Structure Of Sars-Cov-2 Spike Protein In Complex With Three-Nab 8H12, 3E2 And 1C4
Organism: Severe acute respiratory syndrome coronavirus 2, Mus musculus
Method: ELECTRON MICROSCOPY Release Date: 2025-12-10 Classification: VIRAL PROTEIN/IMMUNE SYSTEM |
 |
Cryo-Em Structure Of Sars-Cov-2 Ba.1 Spike Protein In Complex With Three-Nab 8H12, 3E2 And 1C4
Organism: Severe acute respiratory syndrome coronavirus 2, Mus musculus
Method: ELECTRON MICROSCOPY Release Date: 2025-12-10 Classification: VIRAL PROTEIN/IMMUNE SYSTEM |
 |
Cryo-Em Structure Of Sars-Cov-2 Ba.2 Spike Protein In Complex With Triple-Nab 8H12, 3E2 And 1C4 (Local Refinement)
Organism: Severe acute respiratory syndrome coronavirus 2, Mus musculus
Method: ELECTRON MICROSCOPY Release Date: 2025-12-10 Classification: VIRAL PROTEIN/IMMUNE SYSTEM |
 |
The Local Refined Map Of Sars-Cov-2 Eg.5.1 Variant Spike Protein Complexed With Antibody Xgi-171
Organism: Homo sapiens, Severe acute respiratory syndrome coronavirus 2
Method: ELECTRON MICROSCOPY Release Date: 2025-12-10 Classification: VIRAL PROTEIN/IMMUNE SYSTEM |
 |
The Local Refined Map Of Sars-Cov-2 Eg.5.1 Variant Spike Protein Complexed With Antibody Xgi-183
Organism: Homo sapiens, Severe acute respiratory syndrome coronavirus 2
Method: ELECTRON MICROSCOPY Release Date: 2025-12-10 Classification: VIRAL PROTEIN/IMMUNE SYSTEM |
 |
Structure Of Sars-Cov-2 Eg.5.1 Variant Spike Protein Complexed With Antibody Xgi-171
Organism: Homo sapiens, Severe acute respiratory syndrome coronavirus 2
Method: ELECTRON MICROSCOPY Release Date: 2025-12-10 Classification: VIRAL PROTEIN/IMMUNE SYSTEM Ligands: NAG |
 |
The Local Refined Map Of Sars-Cov-2 Eg.5.1 Variant Spike Protein Complexed With Antibody Xgi-198
Organism: Homo sapiens, Severe acute respiratory syndrome coronavirus 2
Method: ELECTRON MICROSCOPY Release Date: 2025-12-10 Classification: VIRAL PROTEIN/IMMUNE SYSTEM |
 |
The Local Refined Map Of Sars-Cov-2 Eg.5.1 Variant Spike Protein Complexed With Antibody Xgi-203
Organism: Severe acute respiratory syndrome coronavirus 2, Homo sapiens
Method: ELECTRON MICROSCOPY Release Date: 2025-12-10 Classification: VIRAL PROTEIN/IMMUNE SYSTEM |
 |
Structure Of Sars-Cov-2 Eg.5.1 Variant Spike Protein Complexed With Antibody Xgi-203
Organism: Homo sapiens, Severe acute respiratory syndrome coronavirus 2
Method: ELECTRON MICROSCOPY Release Date: 2025-12-10 Classification: VIRAL PROTEIN/IMMUNE SYSTEM Ligands: NAG |
 |
Structure Of Sars-Cov-2 Eg.5.1 Variant Spike Protein Complexed With Antibody Xgi-198
Organism: Severe acute respiratory syndrome coronavirus 2, Homo sapiens
Method: ELECTRON MICROSCOPY Release Date: 2025-12-10 Classification: VIRAL PROTEIN/IMMUNE SYSTEM Ligands: NAG |
 |
Crystal Structure Of Sars-Cov-2 Mpro S10A In Complex With Pfizer Intravenous Inhibitor Pf-00835231
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION Release Date: 2025-12-10 Classification: VIRAL PROTEIN Ligands: V2M |
 |
Crystal Structure Of Sars-Cov-2 Mpro S10C In Complex With Pfizer Intravenous Inhibitor Pf-00835231
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION Release Date: 2025-12-10 Classification: VIRAL PROTEIN Ligands: DMS, EDO, V2M |
 |
Crystal Structure Of Sars-Cov-2 Mpro S113A In Complex With Pfizer Intravenous Inhibitor Pf-00835231
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION Release Date: 2025-12-10 Classification: VIRAL PROTEIN Ligands: V2M |
 |
Crystal Structure Of Sars-Cov-2 Mpro S113C In Complex With Pfizer Intravenous Inhibitor Pf-00835231
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION Release Date: 2025-12-10 Classification: VIRAL PROTEIN Ligands: V2M |
 |
Crystal Structure Of Sars-Cov-2 Mpro L115A In Complex With Pfizer Intravenous Inhibitor Pf-00835231
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION Release Date: 2025-12-10 Classification: VIRAL PROTEIN Ligands: V2M |
 |
Crystal Structure Of Sars-Cov-2 Mpro L115M In Complex With Pfizer Intravenous Inhibitor Pf-00835231
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION Release Date: 2025-12-10 Classification: VIRAL PROTEIN Ligands: V2M |
 |
Crystal Structure Of Sars-Cov-2 Mpro S147A In Complex With Pfizer Intravenous Inhibitor Pf-00835231
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION Release Date: 2025-12-10 Classification: VIRAL PROTEIN Ligands: V2M |